Bartholomeusz C, Gonzalez-Angulo AM (2012) Targeting the PI3K signaling pathway in cancer therapy. Expert Opin Ther Targets 16(1):121–130. https://doi.org/10.1517/14728222.2011.644788

Article  CAS  PubMed  Google Scholar 

Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55(4):244–265. https://doi.org/10.1136/jcp.55.4.244

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Candi E, Schmidt R, Melino G (2005) The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6(4):328–340. https://doi.org/10.1038/nrm1619

Article  CAS  PubMed  Google Scholar 

Chatterjee K, Mukherjee S, Vanmanen J, Banerjee P, Fata JE (2019) Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. Front Oncol 9:352. https://doi.org/10.3389/fonc.2019.00352

Article  PubMed  PubMed Central  Google Scholar 

Clough E, Barrett T (2016) The Gene Expression Omnibus database. Methods Mol Biol 1418:93–110. https://doi.org/10.1007/978-1-4939-3578-9_5

Article  PubMed  PubMed Central  Google Scholar 

Feng Y, Ji D, Huang Y, Ji B, Zhang Y, Li J et al (2020) TGM3 functions as a tumor suppressor by repressing epithelial-to-mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer. Oncol Rep 43(3):864–876. https://doi.org/10.3892/or.2020.7474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghayad SE, Cohen PA (2010) Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients. Recent Pat Anticancer Drug Discov 5(1):29–57. https://doi.org/10.2174/157489210789702208

Article  CAS  PubMed  Google Scholar 

Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368(Pt 2):377–396. https://doi.org/10.1042/bj20021234

Article  CAS  PubMed  PubMed Central  Google Scholar 

He C, Sun Z, Hoffman RM, Yang Z, Jiang Y, Wang L, Hao Y (2019) P-glycoprotein overexpression is associated with cisplatin resistance in human osteosarcoma. Anticancer Res 39(4):1711–1718. https://doi.org/10.21873/anticanres.13277

Article  CAS  PubMed  Google Scholar 

Hitomi K (2005) Transglutaminases in skin epidermis. Eur J Dermatol 15(5):313–319

CAS  PubMed  Google Scholar 

Hitomi K, Horio Y, Ikura K, Yamanishi K, Maki M (2001) Analysis of epidermal-type transglutaminase (TGase 3) expression in mouse tissues and cell lines. Int J Biochem Cell Biol 33(5):491–498. https://doi.org/10.1016/s1357-2725(01)00033-4

Article  CAS  PubMed  Google Scholar 

Hu JW, Yang ZF, Li J, Hu B, Luo CB, Zhu K et al (2020) TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection. Dig Liver Dis 52(6):668–676. https://doi.org/10.1016/j.dld.2019.10.010

Article  CAS  PubMed  Google Scholar 

Kalinin AE, Kajava AV, Steinert PM (2002) Epithelial barrier function: assembly and structural features of the cornified cell envelope. BioEssays 24(9):789–800. https://doi.org/10.1002/bies.10144

Article  CAS  PubMed  Google Scholar 

Köberle B, Tomicic MT, Usanova S, Kaina B (2010) Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta 1806(2):172–182. https://doi.org/10.1016/j.bbcan.2010.07.004

Article  CAS  PubMed  Google Scholar 

Li N, Yang L, Wang H, Yi T, Jia X, Chen C, Xu P (2015) MiR-130a and miR-374a function as novel regulators of cisplatin resistance in human ovarian cancer A2780 cells. PLoS One 10(6):e0128886. https://doi.org/10.1371/journal.pone.0128886

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Zhang Z, Zhao W, Han N (2016) Transglutaminase 3 protein modulates human esophageal cancer cell growth by targeting the NF-κB signaling pathway. Oncol Rep 36(3):1723–1730. https://doi.org/10.3892/or.2016.4921

Article  CAS  PubMed  Google Scholar 

Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z et al (2020) PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11(9):797. https://doi.org/10.1038/s41419-020-02998-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loehrer PJ, Einhorn LH (1984) Drugs five years later. Cisplatin. Ann Intern Med 100(5):704–713. https://doi.org/10.7326/0003-4819-100-5-704

Article  CAS  PubMed  Google Scholar 

Luckett R, Feldman S (2016) Will HPV vaccination affect cervical cancer morbidity and mortality world-wide? Hum Vaccin Immunother 12(6):1373–1374. https://doi.org/10.1080/21645515.2016.1162935

Article  PubMed  PubMed Central  Google Scholar 

Shen DW, Pouliot LM, Hall MD, Gottesman MM (2012) Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev 64(3):706–721. https://doi.org/10.1124/pr.111.005637

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22(47):7265–7279. https://doi.org/10.1038/sj.onc.1206933

Article  CAS  PubMed  Google Scholar 

Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de Lourdes BM, Remião F (2015) Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacol Ther 149:1–123. https://doi.org/10.1016/j.pharmthera.2014.11.013

Article  CAS  PubMed  Google Scholar 

Syed SB, Arya H, Fu IH, Yeh TK, Periyasamy L, Hsieh HP et al (2017) Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer. 7 (1):7972. https://doi.org/10.1038/s41598-017-08062-2

Szász AM, Lánczky A, Nagy Á, Förster S, Hark K, Green JE et al (2016) Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget 7(31):49322–49333. https://doi.org/10.18632/oncotarget.10337

Article  PubMed  PubMed Central  Google Scholar 

Tong X, Pelling JC (2013) Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention. Anticancer Agents Med Chem 13(7):971–978. https://doi.org/10.2174/18715206113139990119

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uemura N, Nakanishi Y, Kato H, Saito S, Nagino M, Hirohashi S et al (2009) Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer 124(9):2106–2115. https://doi.org/10.1002/ijc.24194

Article  CAS  PubMed  Google Scholar 

Wang N, Hou MS, Zhan Y, Shen XB, Xue HY (2018) MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway. Eur Rev Med Pharmacol Sci 22(22):7653–7659. https://doi.org/10.26355/eurrev_201811_16382

Article  CAS  PubMed  Google Scholar 

West KA, Castillo SS, Dennis PA (2002) Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5(6):234–248. https://doi.org/10.1016/s1368-7646(02)00120-6

Article  CAS  PubMed  Google Scholar 

Wu X, Cao W, Wang X, Zhang J, Lv Z, Qin X et al (2013) TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol Cancer 12(1):151. https://doi.org/10.1186/1476-4598-12-151

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu L, Cai S, Deng Y, Zhang Z, Zhou X, Su Y, Xu D (2021) PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression. Int Immunopharmacol 94:107443. https://doi.org/10.1016/j.intimp.2021.107443

Article  CAS  PubMed  Google Scholar 

Xiang M, Kidd EA (2019) Benefit of cisplatin with definitive radiotherapy in older women with cervical cancer. J Natl Compr Canc Netw 17(8):969–975. https://doi.org/10.6004/jnccn.2019.7289

Article  PubMed  Google Scholar 

Zhang H, Xu H, Ashby CR Jr, Assaraf YG, Chen ZS, Liu HM (2021) Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp). Med Res Rev 41(1):525–555. https://doi.org/10.1002/med.21739

Article  CAS  PubMed  Google Scholar 

Zhang M, Shi M, Zhao Y (2018) Association between serum copper levels and cervical cancer risk: a meta-analysis. Biosci Rep 38(4). https://doi.org/10.1042/BSR20180161

Zhu H, Luo H, Zhang W, Shen Z, Hu X, Zhu X (2016) Molecular mechanisms of cisplatin resistance in cerv